Real-time enrollment status for this excessive daytime sleepiness clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 9:26 AM UTC
| NCT Number | NCT07082829 |
| Recruiting Status | Recruiting |
| Condition | Excessive Daytime Sleepiness |
| Phase | Clinical Trial |
| Target Enrollment | 208 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Centessa Pharmaceuticals (UK) Limited |
| Last Updated on CT.gov | December 24, 2025 (Dec 24, 2025) |
As of July 13, 2026: Clinical trial NCT07082829 is currently recruiting participants. This clinical trial study for excessive daytime sleepiness is actively seeking new participants at 3 locations across the United States. The study is sponsored by Centessa Pharmaceuticals (UK) Limited. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07082829 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07082829 was last updated Dec 24, 2025 (December 24, 2025). HelloStudys verifies this status automatically.